Company Profiles

driven by the PitchBook Platform

Alcresta Therapeutics

Description

Developer of enzyme-based nutritional products to manage disease for infants, older adults and patients battling acute or chronic conditions. The company offers a line of products with an added microbial enzyme that helps in breaking down complex foods so patients can easily digest them.

2011

Founded

PRIVATE

Status

Series C

Latest Deal Type

$50.9M

Latest Deal Amount

$70.9M

Total Amount Raised

4

Investors

Description

Developer of enzyme-based nutritional products to manage disease for infants, older adults and patients battling acute or chronic conditions. The company offers a line of products with an added microbial enzyme that helps in breaking down complex foods so patients can easily digest them.

Website:

www.alcresta.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Primary Office

One Newton Executive Park Suite 100 Newton, MA 02462United States +1 (617) 431-3600
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Alcresta Therapeutics's full profile, request a free trial.

Alcresta Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Alcresta Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Alcresta Therapeutics Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Athyrium Capital ManagementAsset ManagerMinority000 0000000 0000
Bessemer Venture PartnersVenture CapitalMinority000 0000000 0000
Frazier HealthcareGrowth/ExpansionMinority000 0000000 0000
Third Rock VenturesVenture CapitalMinority000 0000000 0000
Athyrium Capital Management Asset Manager
Bessemer Venture Partners Venture Capital
Frazier Healthcare Growth/Expansion
Third Rock Ventures Venture Capital

Alcresta Therapeutics Executive Team (12)

NameTitleBoard
Seat
Contact
Info
Daniel TasséChairman & Chief Executive Officer
Robert GallottoCo-Founder & President
Anastasios KonidarisChief Financial Officer
Martin PazChief Human Resource Officer
William ScheinlerChief Legal Officer & Secretary
Daniel Tassé Chairman & Chief Executive Officer
Robert Gallotto Co-Founder & President
Anastasios Konidaris Chief Financial Officer
Martin Paz Chief Human Resource Officer
William Scheinler Chief Legal Officer & Secretary

Alcresta Therapeutics Board Members (7)

NameRepresentingRoleSinceContact
Info
Alexey Margolin Ph.DSelfCo-Founder & Board Member000 0000
Daniel TasséAlcresta TherapeuticsChairman & Chief Executive Officer000 0000
James Topper Ph.DFrazier HealthcareManaging General Partner, Life Sciences000 0000
Jeremy Lack Ph.DAthyrium Capital ManagementPartner000 0000
Robert Tepper MDThird Rock VenturesCo-Founder & Partner000 0000
Alexey Margolin Ph.D Co-Founder & Board Member Self
Daniel Tassé Chairman & Chief Executive Officer Alcresta Therapeutics
James Topper Ph.D Managing General Partner, Life Sciences Frazier Healthcare
Jeremy Lack Ph.D Partner Athyrium Capital Management
Robert Tepper MD Co-Founder & Partner Third Rock Ventures
Request full access to PitchBook